HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alf Johansson Selected Research

almokalant

12/2003Teratogenicity by the hERG potassium channel blocking drug almokalant: use of hypoxia marker gives evidence for a hypoxia-related mechanism mediated via embryonic arrhythmia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alf Johansson Research Topics

Disease

2Hypoxia (Hypoxemia)
03/2005 - 12/2003
1Cardiac Arrhythmias (Arrythmia)
12/2003

Drug/Important Bio-Agent (IBA)

2pimonidazoleIBA
03/2005 - 12/2003
1Phenytoin (Dilantin)FDA LinkGeneric
03/2005
1Pharmaceutical PreparationsIBA
12/2003
1Oxygen (Dioxygen)IBA
12/2003
1Potassium Channels (Potassium Channel)IBA
12/2003
1almokalantIBA
12/2003